Goldenwell Biotech, Inc. (GWLL) stock
GWLLOTCFood and Kindred ProductsFiscal year ends December 31
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026Market cap $64.35MP/E –Yield –
Goldenwell Biotech net income
Net income is the profit left for shareholders after every expense, interest and tax.
Goldenwell Biotech's net income for the twelve months ending Jun 30, 2026 was -$282.12K. For fiscal 2025 it was -$296.47K. The highest annual figure on record is -$2.31K in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$296.47K | – |
| FY2024 | Dec 31, 2024 | -$131.50K | – |
| FY2023 | Dec 31, 2023 | -$117.36K | – |
| FY2022 | Dec 31, 2022 | -$985.10K | – |
| FY2021 | Dec 31, 2021 | -$116.98K | – |
| FY2020 | Dec 31, 2020 | -$6.32K | – |
| FY2019 | Dec 31, 2019 | -$2.31K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$36.88K | – |
| Q1 FY2026 | Mar 31, 2026 | -$17.61K | – |
| Q4 FY2025 | Dec 31, 2025 | -$199.74K | – |
| Q3 FY2025 | Sep 30, 2025 | -$27.90K | – |
| Q2 FY2025 | Jun 30, 2025 | -$30.30K | – |
| Q1 FY2025 | Mar 31, 2025 | -$38.54K | – |
| Q4 FY2024 | Dec 31, 2024 | -$27.45K | – |
| Q3 FY2024 | Sep 30, 2024 | -$23.07K | – |
| Q2 FY2024 | Jun 30, 2024 | -$49.92K | – |
| Q1 FY2024 | Mar 31, 2024 | -$30.98K | – |
| Q4 FY2023 | Dec 31, 2023 | -$20.80K | – |
| Q3 FY2023 | Sep 30, 2023 | -$35.41K | – |
| Q2 FY2023 | Jun 30, 2023 | -$27.08K | – |
| Q1 FY2023 | Mar 31, 2023 | -$33.61K | – |
| Q4 FY2022 | Dec 31, 2022 | -$920.33K | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.58K | – |
| Q2 FY2022 | Jun 30, 2022 | -$26.80K | – |
| Q1 FY2022 | Mar 31, 2022 | -$33.38K | – |
| Q4 FY2021 | Dec 31, 2021 | -$29.54K | – |
| Q3 FY2021 | Sep 30, 2021 | -$17.76K | – |
| Q2 FY2021 | Jun 30, 2021 | -$23.58K | – |
| Q1 FY2021 | Mar 31, 2021 | -$46.10K | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.98K | – |
| Q3 FY2020 | Sep 30, 2020 | -$879 | – |
| Q2 FY2020 | Jun 30, 2020 | -$141 | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.33K | – |
| Q4 FY2019 | Dec 31, 2019 | -$323 | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.99K | – |
See a number that looks wrong?